Tania L. Slatter

1.3k total citations
47 papers, 801 citations indexed

About

Tania L. Slatter is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tania L. Slatter has authored 47 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Tania L. Slatter's work include Glioma Diagnosis and Treatment (11 papers), Cancer-related Molecular Pathways (10 papers) and Cancer Research and Treatments (7 papers). Tania L. Slatter is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Cancer-related Molecular Pathways (10 papers) and Cancer Research and Treatments (7 papers). Tania L. Slatter collaborates with scholars based in New Zealand, Australia and United Kingdom. Tania L. Slatter's co-authors include Noelyn Hung, Janice A. Royds, Antony W. Braithwaite, Margaret A. Baird, Hamish G. Campbell, Sunali Mehta, Reena Mehta, Anna Wiles, Michelle Wilson and Carlos Rubio-Terrés and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Tania L. Slatter

45 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tania L. Slatter New Zealand 21 435 269 176 106 98 47 801
Galit Shahaf Israel 16 304 0.7× 136 0.5× 244 1.4× 75 0.7× 46 0.5× 23 801
María Dirlei Begnami Brazil 19 390 0.9× 323 1.2× 158 0.9× 216 2.0× 78 0.8× 51 961
Laibin Liu United States 14 360 0.8× 243 0.9× 77 0.4× 147 1.4× 77 0.8× 19 911
Erhong Meng China 10 296 0.7× 236 0.9× 112 0.6× 34 0.3× 48 0.5× 24 571
F. Alameda Spain 13 312 0.7× 268 1.0× 117 0.7× 75 0.7× 23 0.2× 28 711
Fernando Abarzúa Japan 13 430 1.0× 119 0.4× 46 0.3× 63 0.6× 17 0.2× 23 710
Masafumi Toyoshima Japan 18 494 1.1× 231 0.9× 145 0.8× 152 1.4× 23 0.2× 61 1.1k
Łukasz Szylberg Poland 17 314 0.7× 367 1.4× 211 1.2× 163 1.5× 67 0.7× 81 923
Giannoula Soufla Greece 18 245 0.6× 125 0.5× 84 0.5× 166 1.6× 40 0.4× 33 646
Ching Ouyang United States 15 385 0.9× 578 2.1× 355 2.0× 195 1.8× 32 0.3× 31 1.1k

Countries citing papers authored by Tania L. Slatter

Since Specialization
Citations

This map shows the geographic impact of Tania L. Slatter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania L. Slatter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania L. Slatter more than expected).

Fields of papers citing papers by Tania L. Slatter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tania L. Slatter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania L. Slatter. The network helps show where Tania L. Slatter may publish in the future.

Co-authorship network of co-authors of Tania L. Slatter

This figure shows the co-authorship network connecting the top 25 collaborators of Tania L. Slatter. A scholar is included among the top collaborators of Tania L. Slatter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tania L. Slatter. Tania L. Slatter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reid, Malcolm, et al.. (2025). Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro. Frontiers in Oncology. 15. 1536549–1536549.
2.
Wang, David, Sunali Mehta, Ziad Thotathil, et al.. (2023). Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis. International Journal of Molecular Sciences. 24(2). 1267–1267. 5 indexed citations
3.
Mahajan, Vishakha, et al.. (2023). A pilot study using unique targeted testing of the urogenital microbiome has potential as a predictive test during IVF for implantation outcome. Archives of Gynecology and Obstetrics. 307(6). 1957–1967. 2 indexed citations
4.
Wiles, Anna, Sunali Mehta, Adele G. Woolley, et al.. (2023). Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis. Arthritis Research & Therapy. 25(1). 62–62. 1 indexed citations
5.
Wiggins, George A. R., Nicholas J. Magon, Andrew B. Das, et al.. (2022). Ascorbate content of clinical glioma tissues is related to tumour grade and to global levels of 5-hydroxymethyl cytosine. Scientific Reports. 12(1). 14845–14845. 8 indexed citations
6.
Slatter, Tania L., et al.. (2021). The epithelial sodium channel has a role in breast cancer cell proliferation. Breast Cancer Research and Treatment. 187(1). 31–43. 21 indexed citations
7.
Arsic, Nikola, Tania L. Slatter, Gilles Gadéa, et al.. (2021). Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells. Nature Communications. 12(1). 5463–5463. 20 indexed citations
8.
Slatter, Tania L., Sam Lee, M. Leticia Castro, et al.. (2020). The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy. PLoS ONE. 15(4). e0231470–e0231470. 11 indexed citations
9.
Fisher, Amanda, et al.. (2020). Human Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae. Pathogens. 9(3). 239–239. 4 indexed citations
10.
Mehta, Sunali, Grégory Gimenez, Hamish G. Campbell, et al.. (2019). The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer. Cell Death and Disease. 10(9). 631–631. 32 indexed citations
11.
Hung, Noelyn, Sunali Mehta, Alison M. Rich, et al.. (2017). Tumor protein 53 mutations are enriched in diffuse large B-cell lymphoma with irregular CD19 marker expression. Scientific Reports. 7(1). 1566–1566. 8 indexed citations
12.
Royds, Janice A., Anna P. Pilbrow, Antonio Ahn, et al.. (2016). The rs11515 Polymorphism Is More Frequent and Associated With Aggressive Breast Tumors with Increased ANRIL and Decreased p16INK4a Expression. Frontiers in Oncology. 5. 306–306. 37 indexed citations
13.
Hood, Kylie, Antony W. Braithwaite, R. James Stubbs, et al.. (2015). Alpha-Enolase Is Upregulated on the Cell Surface and Responds to Plasminogen Activation in Mice Expressing a ∆133p53α Mimic. PLoS ONE. 10(2). e0116270–e0116270. 22 indexed citations
14.
Hung, Noelyn, Yu-Jen Chen, Magnus Olivecrona, et al.. (2014). Increased paired box transcription factor 8 has a survival function in Glioma. BMC Cancer. 14(1). 159–159. 12 indexed citations
15.
Berney‐Meyer, Linda, et al.. (2014). Omeprazole‐induced acute interstitial nephritis: A possible Th1–Th17‐mediated injury?. Nephrology. 19(6). 359–365. 28 indexed citations
16.
Campbell, Hamish G., Reena Mehta, Axel A. Neumann, et al.. (2012). Activation of p53 following ionizing radiation, but not other stressors, is dependent on the proline-rich domain (PRD). Oncogene. 32(7). 827–836. 14 indexed citations
17.
Campbell, Hamish G., Tania L. Slatter, Aaron Jeffs, et al.. (2012). Does Δ133p53 isoform trigger inflammation and autoimmunity?. Cell Cycle. 11(3). 446–450. 21 indexed citations
18.
Slatter, Tania L., Anna Wiles, Yu-Jen Chen, et al.. (2010). Pilocytic Astrocytomas Have Telomere-Associated Promyelocytic Leukemia Bodies without Alternatively Lengthened Telomeres. American Journal Of Pathology. 177(6). 2694–2700. 21 indexed citations
19.
Slatter, Tania L., Reena Mehta, Carlos Rubio-Terrés, et al.. (2009). p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors. Cell Death and Differentiation. 17(3). 540–550. 31 indexed citations
20.
Slatter, Tania L., Michael Williams, Ruth Frikke‐Schmidt, et al.. (2005). Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia. Atherosclerosis. 187(2). 393–400. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026